Literature DB >> 21403917

Antitumor activity of antimicrobial peptides against U937 histiocytic cell line.

Patrycja Koszałka1, Elżbieta Kamysz, Magdalena Wejda, Wojciech Kamysz, Jacek Bigda.   

Abstract

We investigated cytotoxic activity of antimicrobial peptides of different origin (both naturally occurring and synthetic), structure and known mechanisms of action against human histiocytic lymphoma cell line U937. The strongest cytotoxic activity against U937 cell line was shown by Pexiganan MSI-78, followed by Citropin 1.1, Protegrin 1 and a synthetic lipopeptide, N-α-palmitoyl-L-lysyl-L-lysine amide (Pal-Lys-Lys-NH₂). The cytotoxic activity of the peptides was more dependent on the time of incubation than concentration. Only for the lipopeptide, whose mode of action was restricted to disruption of electric potential of the cell membrane, the correlation between cytotoxicity and concentration was almost linear. The high cytotoxicity of Pexiganan MSI-78, Protegrin 1 and the lipopeptide could be basically explained by their membranolytic activity leading to necrosis. However, in the case of Citropin 1.1, the cell membrane integrity was disrupted only slightly and independently of the peptide concentration. Therefore, some other mechanism of action might be responsible for its strong dose-dependent cytotoxic activity, e.g., membranolytic activity leading to apoptosis. Furthermore, TNF-α production due to LPS (lipopolysaccharide) stimulation was suppressed by the presence of Citropin 1.1, Pexiganan MSI-78 or Protegrin 1, but not by Buforin 2 or the lipopeptide. Our experiments have shown that cytotoxic activity is not limited to some specific molecular structure of a peptide, but rather to the length of the peptide chain as it is likely to affect the efficiency of the tumor cell membrane disruption and interaction with LPS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21403917

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  10 in total

Review 1.  Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects.

Authors:  Amy A Baxter; Fung T Lay; Ivan K H Poon; Marc Kvansakul; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2017-08-02       Impact factor: 9.261

2.  Targeting and eradicating hepatic cancer cells with a cancer-specific vector carrying the Buforin II gene.

Authors:  Yanyun Wang; Lili Qu; Lailing Gong; Li Sun; Rujun Gong; Jin Si
Journal:  Cancer Biother Radiopharm       Date:  2013-06-25       Impact factor: 3.099

Review 3.  Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.

Authors:  Sabrina Riedl; Dagmar Zweytick; Karl Lohner
Journal:  Chem Phys Lipids       Date:  2011-09-16       Impact factor: 3.329

4.  Combination treatment of ergosterol followed by amphotericin B induces necrotic cell death in human hepatocellular carcinoma cells.

Authors:  Yu-Chun Lin; Bao-Hong Lee; Jassey Alagie; Ching-Hua Su
Journal:  Oncotarget       Date:  2017-08-16

Review 5.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640

6.  Host-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidae.

Authors:  J Michael Conlon; Milena Mechkarska
Journal:  Pharmaceuticals (Basel)       Date:  2014-01-15

7.  Antimicrobial peptides: versatile biological properties.

Authors:  Muthuirulan Pushpanathan; Paramasamy Gunasekaran; Jeyaprakash Rajendhran
Journal:  Int J Pept       Date:  2013-06-26

8.  pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates.

Authors:  Kelly E Burns; Tanner P McCleerey; Damien Thévenin
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

9.  Cathelicidins display conserved direct antiviral activity towards rhinovirus.

Authors:  Filipa Henderson Sousa; Victor Casanova; Fern Findlay; Craig Stevens; Pavel Svoboda; Jan Pohl; Lorna Proudfoot; Peter G Barlow
Journal:  Peptides       Date:  2017-07-29       Impact factor: 3.750

10.  The Spectrum of Design Solutions for Improving the Activity-Selectivity Product of Peptide Antibiotics against Multidrug-Resistant Bacteria and Prostate Cancer PC-3 Cells.

Authors:  Davor Juretić; Anja Golemac; Denise E Strand; Keshi Chung; Nada Ilić; Ivana Goić-Barišić; François-Xavier Pellay
Journal:  Molecules       Date:  2020-08-01       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.